Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
Cord Blood CD34+ (batch ≥2 million cells)
Catalog #: 2C-101X
Cryopreserved ampule of Human Cord Blood CD34+ stem/progenitors
Primary Cell Optimization 4D-Nucleofector™ Y Kit
Catalog #: V4YP-9A48
For rapid determination of Nucleofection conditions for primary cell types lacking an Optimized Protocol for the 4D-NucleofectorTM Y Unit.
HRCE – Human Renal Cortical Epithelial Cells
Catalog #: CC-2554
Cryopreserved ampule of Renal Cortical Epithelial Cells (HRCE) containing ≥500,000 cells
X-VIVOTM 10 Serum-free Hematopoietic Cell Medium
Catalog #: BE04-380Q
X-VIVO™ 10, Serum free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 L
Por-CASMC - Porcine Coronary Artery Smooth Muscle Cells
Catalog #: 00227730
Limited Edition Porcine Coronary Artery Smooth Muscle Cells
HAEC – Human Aortic Endothelial Cells
Catalog #: CC-2535
Cryopreserved ampule of Human Aortic Endothelial Cells (HAEC) containing ≥ 500,000 cells
HCAEC – Human Coronary Artery Endothelial Cells
Catalog #: CC-2585
Cryopreserved ampule of Human Coronary Artery Endothelial Cells (HCAEC) containing ≥ 500,000 cells
Human CD19+ B Cells (10 Million Cells, Positive Selection)
Catalog #: 4W-600
Human CD19+ B cells isolated from peripheral blood using positive immunomagnetic selection, cryopreserved, ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 6 Collection,Full Bag)
Catalog #: 3Y-300D
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 ug/kg x 5, Mozobil 240 ug/kg x 2, Day 6 Collection, 1 Bag
Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 5 Collection, Full Bag)
Catalog #: 3Y-300A
Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 ug/kg x 5, Mozobil 240 ug/kg x 2, Day 5 Collection, 1 Bag
Added to Your Shopping Cart
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
Product Availability by Store Location
Hours